Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Cancer Medicine|May 27, 2022
A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancerBaihua Zhang, Haifan Xiao, Xingxiang Pu, et al.
Medicine|February 9, 2018
Association of microRNA-423 rs6505162 C>A polymorphism with susceptibility and metastasis of colorectal carcinomaWenrui Jia, Liuyan Zeng, Shengqun Luo, et al.
Thoracic Cancer|July 24, 2022
Perivascular epithelioid cell tumor of the lung: A case report and literature reviewShaofu Yu, Shasha Zhai, Qian Gong, et al.
BMC Cancer|October 15, 2023
Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort studyXingxiang Pu, Yu Zhou, Yi Kong, et al.
Frontiers in Oncology|September 2, 2022
Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinomaMeilin Jiang, Pei Yang, Jing Li, et al.
Plos One|November 20, 2014
Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysisDan Liao, Yongfu Wu, Xingxiang Pu, et al.
Experimental and Therapeutic Medicine|February 14, 2018
miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cellsDan Liao, Tong Li, Caiguo Ye, et al.
The Oncologist|May 11, 2025
Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC and brain metastasis: a multicenter cohort studyPuyuan Xing, Xingxiang Pu, Yu Zhou, et al.
Oncology Letters|December 21, 2012
Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implicationsXingxiang Pu, Zhizhong Pan, Ying Huang, et al.
Biology Direct|October 16, 2024
ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathwayWei Zhai, Wensheng Yang, Jing Ge, et al.
Pageof 8